Atlas Trials

Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression

Clinical trial NCT04798612 · UNKNOWN

Trial details

NCT number
NCT04798612
Sponsor
Zealand University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2023-08-14
Primary completion
2025-08-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.